5月20日,复星医药(600196/02196)发布公告,近日公司董事会收到RongYang的书面辞职函,因个人原因申请辞去高级副总裁职务。RongYang先生自2025年5月16日起不再担任公司高级副总裁职务。2025年一季度,复星医药实现收入94.20亿元,归母净利润7.65亿元。文章来源:财中社原标题:复星医药高级副总裁RongYang辞职
Source Link5月20日,复星医药(600196/02196)发布公告,近日公司董事会收到RongYang的书面辞职函,因个人原因申请辞去高级副总裁职务。RongYang先生自2025年5月16日起不再担任公司高级副总裁职务。2025年一季度,复星医药实现收入94.20亿元,归母净利润7.65亿元。文章来源:财中社原标题:复星医药高级副总裁RongYang辞职
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.